• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多中心国际研究中精神分裂症中间措施跨文化调适的定性评估。

A qualitative assessment of cross-cultural adaptation of intermediate measures for schizophrenia in multisite international studies.

机构信息

Department of Psychiatry, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

出版信息

Psychiatry Res. 2013 Apr 30;206(2-3):166-72. doi: 10.1016/j.psychres.2012.10.015. Epub 2012 Nov 17.

DOI:10.1016/j.psychres.2012.10.015
PMID:23167987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3615112/
Abstract

In this substudy of the Measurement and Treatment Research to Improve Cognition in Schizophrenia we examined qualitative feedback on the cross-cultural adaptability of four intermediate measures of functional outcome (Independent Living Scales, UCSD Performance-Based Skills Assessment, Test of Adaptive Behavior in Schizophrenia, and Cognitive Assessment Interview). Feedback was provided by experienced English-fluent clinical researchers at 31 sites in eight countries familiar with medication trials. Researchers provided feedback on test subscales and items which were rated as having adaptation challenges. They noted the specific concern and made suggestions for adaptation to their culture. We analyzed the qualitative data using a modified Grounded Theory approach guided by the International Testing Commission Guidelines model for test adaptation. For each measure except the Cognitive Assessment Interview (CAI), the majority of subscales were reported to require major adaptations in terms of content and concepts contained in the subscale. In particular, social, financial, transportation and health care systems varied widely across countries-systems which are often used to assess performance capacity in the U.S. We provide suggestions for how to address future international test development and adaptation.

摘要

在这项改善精神分裂症认知的测量和治疗研究的子研究中,我们检查了对四项功能结果中间测量(独立生活量表、加州大学圣地亚哥表现性技能评估、精神分裂症适应行为测验和认知评估访谈)的跨文化适应性的定性反馈。反馈来自 8 个国家 31 个地点经验丰富的讲英语的临床研究人员,他们熟悉药物试验。研究人员对被评为具有适应性挑战的测试子量表和项目提供反馈。他们指出了具体的关注点,并就如何适应他们的文化提出了建议。我们使用一种改良的扎根理论方法,根据国际测试委员会指南模型对测试适应性进行分析。除认知评估访谈(CAI)外,大多数子量表在子量表中包含的内容和概念方面都需要进行重大改编。特别是,社会、金融、交通和医疗保健系统在各国之间差异很大,而这些系统在美国通常用于评估绩效能力。我们提供了如何解决未来国际测试开发和适应性的建议。

相似文献

1
A qualitative assessment of cross-cultural adaptation of intermediate measures for schizophrenia in multisite international studies.多中心国际研究中精神分裂症中间措施跨文化调适的定性评估。
Psychiatry Res. 2013 Apr 30;206(2-3):166-72. doi: 10.1016/j.psychres.2012.10.015. Epub 2012 Nov 17.
2
The cultural adaptability of intermediate measures of functional outcome in schizophrenia.精神分裂症中间功能结局测量的文化适应性。
Schizophr Bull. 2012 May;38(3):630-41. doi: 10.1093/schbul/sbq136. Epub 2010 Dec 6.
3
The reliability and validity of the MATRICS functional assessment battery.MATRICS功能评估量表的信度和效度。
Schizophr Bull. 2014 Sep;40(5):1047-52. doi: 10.1093/schbul/sbt148. Epub 2013 Nov 9.
4
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.精神分裂症认知评定量表:一种基于访谈的评估及其与认知、现实世界功能和功能能力的关系。
Am J Psychiatry. 2006 Mar;163(3):426-32. doi: 10.1176/appi.ajp.163.3.426.
5
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.精神分裂症临床试验的功能性共同主要指标:MATRICS心理测量与标准化研究结果
Am J Psychiatry. 2008 Feb;165(2):221-8. doi: 10.1176/appi.ajp.2007.07010089. Epub 2008 Jan 2.
6
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
7
Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.虚拟现实评估精神分裂症早期的功能能力:与认知表现和日常功能的关系。
Early Interv Psychiatry. 2020 Feb;14(1):106-114. doi: 10.1111/eip.12831. Epub 2019 Jun 10.
8
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.精神分裂症患者现实世界功能表现的决定因素:与认知、功能能力及症状的相关性
Am J Psychiatry. 2006 Mar;163(3):418-25. doi: 10.1176/appi.ajp.163.3.418.
9
Validating the measurement of real-world functional outcomes: phase I results of the VALERO study.验证真实世界功能结局测量的有效性:VALERO 研究的 I 期结果。
Am J Psychiatry. 2011 Nov;168(11):1195-201. doi: 10.1176/appi.ajp.2011.10121723. Epub 2011 May 15.
10
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia.评估精神分裂症认知增强临床试验中具有临床意义的测量指标。
Am J Psychiatry. 2011 Apr;168(4):400-7. doi: 10.1176/appi.ajp.2010.10030414. Epub 2011 Feb 1.

引用本文的文献

1
Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study.评估精神分裂症认知评定量表的评分者间信度:一项非干预性定量研究。
Schizophrenia (Heidelb). 2025 Apr 28;11(1):71. doi: 10.1038/s41537-025-00619-9.
2
Harmonizing cross-cultural and transdiagnostic assessment of social cognition by expert panel consensus.通过专家小组共识协调社会认知的跨文化和跨诊断评估。
Schizophrenia (Heidelb). 2025 Feb 21;11(1):25. doi: 10.1038/s41537-024-00540-7.
3
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials.致力于改进治疗与精神分裂症及其他神经精神疾病相关认知障碍的药物研发方法:二十年临床试验的见解
Schizophr Bull. 2025 Mar 14;51(2):262-273. doi: 10.1093/schbul/sbae151.
4
International perspective on social cognition in schizophrenia: current stage and the next steps.精神分裂症社会认知的国际视角:当前阶段与下一步措施
Eur Psychiatry. 2025 Jan 15;68(1):e9. doi: 10.1192/j.eurpsy.2024.1776.
5
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities.在临床实践中测量与精神分裂症相关的认知障碍:当前挑战与未来机遇概述
Schizophr Bull. 2025 Mar 14;51(2):401-421. doi: 10.1093/schbul/sbae051.
6
European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.欧洲精神病学协会关于精神分裂症认知障碍评估的指南。
Eur Psychiatry. 2022 Sep 5;65(1):e58. doi: 10.1192/j.eurpsy.2022.2316.
7
Utility of the UCSD Performance-based Skills Assessment-Brief Japanese version: discriminative ability and relation to neurocognition.加州大学圣地亚哥分校基于表现的技能评估简版日语版本的效用:鉴别能力及其与神经认知的关系。
Schizophr Res Cogn. 2014 Oct 12;1(3):137-143. doi: 10.1016/j.scog.2014.08.002. eCollection 2014 Sep.
8
The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity.加利福尼亚大学圣地亚哥分校基于表现的技能评估韩语版:信度与效度
Clin Psychopharmacol Neurosci. 2017 Aug 31;15(3):261-268. doi: 10.9758/cpn.2017.15.3.261.
9
Using the cognitive assessment interview to screen cognitive impairment in psychosis.使用认知评估访谈筛查精神病患者的认知障碍。
Eur Arch Psychiatry Clin Neurosci. 2016 Oct;266(7):629-37. doi: 10.1007/s00406-016-0700-y. Epub 2016 Jun 6.
10
Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia.认知评估访谈(CAI):作为精神分裂症各阶段认知共同主要测量指标的效度
Schizophr Res. 2016 Apr;172(1-3):137-42. doi: 10.1016/j.schres.2016.01.028. Epub 2016 Feb 4.

本文引用的文献

1
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia.评估精神分裂症认知增强临床试验中具有临床意义的测量指标。
Am J Psychiatry. 2011 Apr;168(4):400-7. doi: 10.1176/appi.ajp.2010.10030414. Epub 2011 Feb 1.
2
The cultural adaptability of intermediate measures of functional outcome in schizophrenia.精神分裂症中间功能结局测量的文化适应性。
Schizophr Bull. 2012 May;38(3):630-41. doi: 10.1093/schbul/sbq136. Epub 2010 Dec 6.
3
Adaptation of Western measures of cognition for assessing 5-year-old semi-urban Ugandan children.将西方认知测量工具改编用于评估半城市环境下的 5 岁乌干达儿童。
Br J Educ Psychol. 2010 Mar;80(Pt 1):15-30. doi: 10.1348/000709909X460600. Epub 2009 Jul 11.
4
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.精神分裂症临床试验的功能性共同主要指标:MATRICS心理测量与标准化研究结果
Am J Psychiatry. 2008 Feb;165(2):221-8. doi: 10.1176/appi.ajp.2007.07010089. Epub 2008 Jan 2.
5
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS).精神分裂症适应行为测试(TABS)的信度和效度。
Psychiatry Res. 2007 May 30;151(1-2):55-66. doi: 10.1016/j.psychres.2006.10.007. Epub 2007 Mar 26.
6
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.精神分裂症认知评定量表:一种基于访谈的评估及其与认知、现实世界功能和功能能力的关系。
Am J Psychiatry. 2006 Mar;163(3):426-32. doi: 10.1176/appi.ajp.163.3.426.
7
Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference.在人类和动物研究中区分可分离的认知领域:何种分离方式最适合靶向干预?精神分裂症认知改善新方法会议测量与治疗研究分组2的建议总结
Schizophr Bull. 2005 Oct;31(4):870-4. doi: 10.1093/schbul/sbi047. Epub 2005 Sep 8.
8
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.美国食品药品监督管理局(FDA)-美国国立精神卫生研究所(NIMH)-精神分裂症临床试验测量与研究国际联盟(MATRICS)关于精神分裂症神经认知药物临床试验设计研讨会综述
Schizophr Bull. 2005 Jan;31(1):5-19. doi: 10.1093/schbul/sbi020. Epub 2005 Feb 16.
9
UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.加州大学圣地亚哥分校基于表现的技能评估:为重度成年精神病患者开发一种新的日常功能测量方法。
Schizophr Bull. 2001;27(2):235-45. doi: 10.1093/oxfordjournals.schbul.a006870.
10
The functional significance of symptomatology and cognitive function in schizophrenia.精神分裂症中症状学和认知功能的功能意义。
Schizophr Res. 1997 May 3;25(1):21-31. doi: 10.1016/S0920-9964(97)00010-8.